Advertisement

PAHC

Phibro Animal Health Corporation

Healthcare · USD

Set alert

Price alert · PAHC

All alert types
38.88 USD +0.02 +0.05%
As of Oct 30, 2026 Extended hours 38.88 0.00%
Bid
38.89 × 2
Ask
38.92 × 2
38.49 Day range 39.95
28.52 52-week range 59.58
YTD
+4.07%
1 year
-7.12%
Open
39.38
Prev close
38.86
Mkt cap
1.58B
Vol
182.78K
Avg vol
220.26K
EPS
2.43
P/E
16.00
Div yield
1.24%
More statistics
Low
38.49
High
39.95
Forward P/E
10.10
Beta
0.42
Short ratio
4.10
Inst. own
102.87%
Dividend
0.48
Ex-div date
Sep 1, 2026
Earnings
Nov 4, 2026
50-d avg
36.92
200-d avg
41.27
1y target
47.00

2Y chart

Chart tools
Interval
PAHC two-year price chart16.227.138.149.160.1Oct 24Mar 25Aug 25Jan 26Jun 26Oct 26

Key statistics

Market cap
1.58B
Enterprise value
2.29B
Trailing P/E
16.00
Forward P/E
10.10
PEG ratio
1.68
Price / sales
1.04
Price / book
4.09
EPS (TTM)
2.43
Beta
0.42
Dividend yield
1.24%
Payout ratio
19.75%
Profit margin
6.57%
Revenue (TTM)
1.52B
Revenue growth
4.80%
Free cash flow
-19.30M
Total cash
83.98M
Total debt
795.65M
Return on equity
29.72%
Shares outstanding
21.11M
Short % of float
7.09%
50-day average
36.92
200-day average
41.27

Analyst view

Consensus: hold

Hold
Price target (mean) 47.00 +20.9% upside
Target (low)
37.00
Target (mean)
47.00
Target (high)
55.00
Ratings (0m) 3 1 buy · 2 hold · 0 sell
  • Strong buy1
  • Buy0
  • Hold2
  • Sell0
  • Strong sell0

Next earnings

Nov 4, 2026

Expected Nov 4, 2026. Consensus EPS estimate 0.78267.

Earnings history

Financials — quick view

All financials
PAHC Revenue — quarterly 396.75M
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026
PAHC Net income — quarterly 21.71M
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026
PAHC EPS — quarterly 0.54
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026

Earnings

PAHC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 4, 2026Sep 30, 20260.783———
Aug 26, 2026Jun 30, 20260.7130.85+0.14+19.21%
May 6, 2026Mar 31, 20260.720.76+0.04+5.56%
Feb 4, 2026Dec 31, 20250.690.87+0.18+26.09%
Nov 5, 2025Sep 30, 20250.590.73+0.14+23.73%
Aug 27, 2025Jun 30, 20250.520.57+0.05+9.62%

Upgrades / downgrades

PAHC analyst upgrades and downgrades
DateFirmActionFromTo
May 14, 2026CitigroupmainNeutralNeutral
Apr 15, 2026Citigroupinit—Neutral
Nov 7, 2025JP MorganmainOverweightOverweight
Aug 29, 2025B of A SecuritiesmainUnderperformUnderperform
Jul 7, 2025JP MorganupNeutralOverweight
Jun 25, 2025Morgan StanleymainEqual-WeightEqual-Weight

About Phibro Animal Health Corporation

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Website
pahc.com

News

Your note

Sign in to keep a note on PAHC — it syncs with the Stock Master app.

Insider holders

PAHC insider holders
InsiderRelationLatest transactionDateShares held
ANDOLINO ANTHONYOfficer and TreasurerStock Award(Grant)Aug 14, 20251,793
BENDHEIM DANIEL MChief Executive OfficerStock Award(Grant)Aug 5, 202615,177
BENDHEIM JACK COfficer, Director and Beneficial OwnerStock Award(Grant)Aug 5, 202682,792
BENDHEIM JACK CLIFFORDChief Executive OfficerSaleApr 29, 20260
BENDHEIM JONATHANDirectorStock Award(Grant)Aug 5, 20265,984
CORCORAN E. THOMASDirectorPurchaseMay 28, 202641,459

Institution ownership

PAHC institution ownership
Holder% heldSharesValueReported
Blackrock Inc.15.25%3,219,040125.16MJun 29, 2026
FMR, LLC14.97%3,160,281122.87MJun 29, 2026
State Street Corporation4.92%1,038,38240.37MJun 29, 2026
Millennium Management Llc4.44%936,70136.42MJun 29, 2026
Vanguard Capital Management LLC4.37%923,31835.90MJun 29, 2026
Geode Capital Management, LLC3.11%657,35025.56MJun 29, 2026

Fund ownership

PAHC fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.94%1,253,78348.75MSep 29, 2026
Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund3.75%792,40130.81MJul 30, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.13%659,62625.65MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.61%551,53621.44MSep 29, 2026
Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total 1.92%405,23515.76MAug 30, 2026
LORD ABBETT SECURITIES TRUST-Lord Abbett Value Opportunities Fund1.63%343,78113.37MJul 30, 2026
Advertisement